Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sorin gets European rights to Respicardia's sleep apnea device, plus option to buy company; deal later terminated

Executive Summary

Cardiovascular device firm Sorin Group SPA acquired exclusive rights to distribute Respicardia Inc.’s (implantable therapies to improve respiratory and cardiovascular health) remede neurostimulation system for central sleep apnea (CSA) in select European countries for five years.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Equity
    • Marketing (Licensing)

Related Companies